Alaunos Therapeutics (TCRT) Cash from Investing Activities Growth (1y) (2010 - 2023)
Alaunos Therapeutics (TCRT) Cash from Investing Activities Growth (1y) (2010 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
1,716.13% |
| Sep 30, 2023 |
107.14% |
| Jun 30, 2023 |
-136.84% |
| Mar 31, 2023 |
20.69% |
| Dec 31, 2022 |
74.09% |
| Sep 30, 2022 |
96.22% |
| Jun 30, 2022 |
96.96% |
| Mar 31, 2022 |
95.96% |
| Dec 31, 2021 |
90.47% |
| Sep 30, 2021 |
81.61% |
| Jun 30, 2021 |
46.17% |
| Mar 31, 2021 |
-39.77% |
| Dec 31, 2020 |
-3,666.00% |
| Sep 30, 2020 |
-1,780.37% |
| Jun 30, 2020 |
-5,104.48% |
| Mar 31, 2020 |
-5,030.00% |
| Dec 31, 2019 |
-216.28% |
| Sep 30, 2019 |
36.69% |
| Jun 30, 2019 |
70.35% |
| Mar 31, 2019 |
93.33% |
